Author:
Koomen David C.,Guingab-Cagmat Joy D.,Oliveira Paula S.,Fang Bin,Liu Min,Welsh Eric A.,Meads Mark B.,Nguyen Tuan,Meke Laurel,Eschrich Steven A.,Shain Kenneth H.,Garrett Timothy J.,Koomen John M.
Reference54 articles.
1. Kumar SK, Rajkumar SV (2018) The multiple myelomas–current concepts in cytogenetic classification and therapy. Nat Rev Clin Oncol. https://doi.org/10.1038/s41571-018-0018-y
2. Sharma V, Eckels J, Schilling B, Ludwig C, Jaffe JD, MacCoss MJ, MacLean B (2018) Panorama public: a public repository for quantitative data sets processed in skyline. Mol Cell Proteomics. https://doi.org/10.1074/mcp.RA117.000543
3. Mateos MV, San Miguel JF (2017) Management of multiple myeloma in the newly diagnosed patient. Hematology Am Soc Hematol Educ Program 2017(1):498–507. https://doi.org/10.1182/asheducation-2017.1.498
4. Bergsagel DE, Sprague CC, Austin C, Griffith KM (1962) Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-phenylalanine mustard (NSC-8806). Cancer Chemother Rep 21:87–99
5. Bernard J, Seligmann M, Danon F (1962) Attempt at treatment of 21 patients with myeloma or macroglobulinemia with p-di-2-chlorethylamino-1-phenylalanine (melphalan). Nouv Rev Fr Hematol 2:611–616
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献